PER 0.00% 7.5¢ percheron therapeutics limited

Ann: ATL1102 Revised Plans accelerate reporting of unblinded data, page-74

  1. 236 Posts.
    lightbulb Created with Sketch. 59
    Last patient dosed 3rd quarter 2023 6 month post last patient dosed before trial ends, that would mean possibly sometime 1st quarter 2024 for results. Or did i get that wrong?
 
watchlist Created with Sketch. Add PER (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.